```json
{
"content": [
{
"type": "faq",
"items": [
{
"Q": "What is the current Rapid Antimicrobial Susceptibility Testing market size?",
"A": "The Rapid Antimicrobial Susceptibility Testing market size surpassed USD 1.4 billion in 2023, driven by rising AMR awareness and hospital demand for rapid diagnostics."
},
{
"Q": "What is the projected growth rate for the 2024–2030 window?",
"A": "Forecasts peg a CAGR of 8.1%, pushing the industry to USD 2.3 billion by 2030, fueled by precision medicine, automation, and stewardship mandates."
},
{
"Q": "What are the key growth drivers in this space?",
"A": "Antimicrobial resistance escalation, reduced turnaround time needs, government funding, AI-enhanced platforms, and reimbursement for rapid AST are primary drivers."
},
{
"Q": "Which challenges could slow adoption?",
"A": "High instrument cost, fragmented regulatory pathways, data interpretation complexity, and lack of universal AST breakpoints hinder widespread uptake."
},
{
"Q": "Which regions dominate revenue share?",
"A": "North America leads with 42% share from strong stewardship programs, followed by Europe (25%) and Asia-Pacific (20%) due to infection burden and health spending."
},
{
"Q": "Who are the top companies today?",
"A": "BD, bioMérieux, Thermo Fisher, Bruker, Danaher, Accelerate Diagnostics, and Liofilchem lead via cartridge systems, MALDI-TOF, and AI software portfolios."
},
"Q": "What future opportunities should organizations act on?",
"A": "Cloud-based susceptibility dashboards, point-of-care cartridges for LMICs, companion diagnostics, and partnerships with pharma for stewardship programs open new revenue streams."
},
{
"Q": "How is technology reshaping the landscape?",
"A": "AI pattern recognition, digital microscopy, nanopore sequencing, microfluidics, and cloud analytics cut result time by 70% while improving accuracy and workflow integration."
},
{
"Q": "How is the regulatory landscape changing?",
"A": "FDA breakthrough device designations, EU IVDDR compliance deadlines, and WHO Essential Diagnostics List additions are accelerating approvals and aligning quality benchmarks globally."
}
]
}
]
}
```
